Rallybio Corporation
RLYB
$9.41
-$0.09-0.95%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/6/2026
-
TipRanks Financial Blog
3/6/2026
-
PR Newswire
3/5/2026
-
MarketBeat
3/4/2026
-
Business Wire
3/3/2026
-
Yahoo! Finance: News
3/3/2026
-
Pharmaceutical Business Review
3/2/2026
-
Seeking Alpha: Transcripts
3/2/2026
-
PR Newswire
3/2/2026
-
TipRanks Financial Blog
3/2/2026
-
Business Wire
3/2/2026
-
MarketBeat
3/2/2026
-
Seeking Alpha - Healthcare
3/2/2026
-
The Fly
3/2/2026
-
The Fly
3/2/2026
-
Business Wire
3/2/2026
-
Business Wire
3/2/2026
-
FierceBiotech.com - Biotech
2/25/2026
-
Zacks Investment Research
2/17/2026
-
Benzinga
2/17/2026
-
Zacks Investment Research
2/17/2026
-
Business Wire
2/6/2026
-
TipRanks Financial Blog
2/6/2026
-
The Fly
2/3/2026
-
Seeking Alpha - Healthcare
2/3/2026
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
203 859 3820
Address
234 Church Street
New Haven, CT 06510
New Haven, CT 06510
Country
Year Founded
Business Description
Sector
Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its...
more